Public, NASDAQ:GERN
NASDAQ Global Market
Market Report -- In Play (WIRES)
Date: Thu, 19 Jun 2008 12:33:15 GMT
Tags:
Market Report -- In Play (WIRES)
MSN Money - Jun 19, 2008
MSN Money - Jun 19, 2008
On The Wires Start Licensing , a JV between Geron ( GERN ) and Exeter , reaffirmed that it controls key patents in Korea and elsewhere that cover animal cloning technology , including the technology ...
Geron Says Its Embryonic Cells Won't Make Immune System React
Date: Fri, 13 Jun 2008 15:42:34 GMT
Tags:
Geron Says Its Embryonic Cells Won't Make Immune System React
Bloomberg - Jun 13, 2008
Geron Presents Data at ISSCR Showing That Its Embryonic Stem Cell Therapeutic for Heart Failure Evades Direct Attack by the Human Immune System - Business Wire (press release)
Bloomberg - Jun 13, 2008
June 12 ( Bloomberg ) - - Geron Corp . said it may be able to inject its experimental stem cells into people to treat heart failure without triggering a life - threatening response by the body's ...
Geron says stem cell treatment does well in early tests - MSN MoneyGeron Presents Data at ISSCR Showing That Its Embryonic Stem Cell Therapeutic for Heart Failure Evades Direct Attack by the Human Immune System - Business Wire (press release)
Geron's Embryonic Stem Cell Treatment Found Effective in Heart Failure Study
Date: Fri, 13 Jun 2008 15:11:57 GMT
Tags:
Geron's Embryonic Stem Cell Treatment Found Effective in Heart Failure Study
RedOrbit - Jun 13, 2008
RedOrbit - Jun 13, 2008
Geron has presented encouraging results from research studies which show that GRNCM1 , the company's human embryonic stem cell - based therapeutic for the treatment of heart failure , evades ...
Geron: Embryonic stem cell therapy for heart failure evades immune system attack
Date: Thu, 12 Jun 2008 15:13:06 GMT
Tags:
Geron: Embryonic stem cell therapy for heart failure evades immune system attack
Forbes - Jun 12, 2008
Forbes - Jun 12, 2008
NEW YORK ( Thomson Financial ) - Shares of Geron Corp . rose in early trading Thursday after the company said it has research studies that show its human embryonic stem cell - based therapy for ...
Market Report -- In Play (GERN)
Date: Thu, 12 Jun 2008 12:17:30 GMT
Tags:
Market Report -- In Play (GERN)
MSN Money - Jun 12, 2008
MSN Money - Jun 12, 2008
Geron presents data showing that its embryonic stem cell therapeutic for heart failure evades direct attack by the human immune system Co announces the presentation of research studies indicating ...
Start Licensing, Inc. Reaffirms Control of Key Cloning Patents (Business Wire)
Date: Thu, 19 Jun 2008 12:00:00 Etc/GMT
Tags:
AUSTIN, Texas----Today Start Licensing, Inc. reaffirmed that it controls key patents in Korea and elsewhere that cover animal cloning technology, including the technology used to clone dogs.
Geron says stem cell treatment does well in early tests (at bizjournals.com)
Date: Thu, 12 Jun 2008 20:45:17 Etc/GMT
Tags:
Geron Corp. says stem cell treatment does well in early tests (at bizjournals.com)
Date: Thu, 12 Jun 2008 18:15:16 Etc/GMT
Tags:
Geron Presents Data at ISSCR Showing That Its Embryonic Stem Cell Therapeutic for Heart Failure Evades Direct Attack by the Human Immune System (Business Wire)
Date: Thu, 12 Jun 2008 11:30:00 Etc/GMT
Tags:
MENLO PARK, Calif.----Geron Corporation today announced the presentation of research studies indicating that GRNCM1, the company's human embryonic stem cell -based therapeutic for the treatment of heart failure, evades direct attack by the human immune system in vitro.
Wall Street Media Presents Exclusive Videos from the Needham Biotech Conference (Business Wire)
Date: Wed, 11 Jun 2008 22:27:00 Etc/GMT
Tags:
NEW YORK----Wall Street Media is presenting exclusive highlight videos from the presentations of Varian Medical Systems Inc., , Geron Corp., , and CuraGen Corp., , at the Needham 7th Annual Biotechnology & Medical Technology Conference at the New York Palace Hotel on June 11-12, 2008.